oncology market
Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.
Hypofractionation could expand radiotherapy access for 2.2 million patients
Between 2015 and 2035, the economic benefits of radiotherapy investments range from $278.1b to $365.4b.
China emerges as key player in oncology with antibody-drug conjugates surge
It represents 82% of the ADC pipeline in major APAC markets.
What’s driving the global gastric cancer diagnostics market?
One key trend is the integration of molecular diagnostics such as next-generation sequencing.
APAC to record fastest-growing interventional oncology market
There has been an expanding research base across India, China, and Japan.